Farther Finance Advisors’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $141 | Hold |
99
| – | – | ﹤0.01% | 4257 |
|
|
2025
Q1 | $147 | Hold |
99
| – | – | ﹤0.01% | 4008 |
|
|
2024
Q4 | $246 | Hold |
99
| – | – | ﹤0.01% | 3607 |
|
|
2024
Q3 | $114 | Hold |
99
| – | – | ﹤0.01% | 3756 |
|
|
2024
Q2 | $114 | Hold |
99
| – | – | ﹤0.01% | 3582 |
|
|
2024
Q1 | $125 | Buy |
99
+34
| +52% | +$43 | ﹤0.01% | 3345 |
|
|
2023
Q4 | $68 | Buy |
+65
| New | +$68 | ﹤0.01% | 3348 |
|